Alimentiv

Industry-leading specialty GI contract research organization (CRO) transforming clinical trial outcomes and accelerating the development of life-changing therapies. We bring together deep GI expertise, advanced medical imaging solutions, clinical operation excellence and cutting-edge precision medicine/laboratory services.

With a global network of 5,000+ sites in >60 countries and growing, we expedite study activation and maximize patient enrollment, ensuring efficient and impactful clinical trials. Trusted by pharmaceutical and biotech partners, we support over 70% of all IBD compounds in development today – delivering customized end-to-end solutions to bring novel therapies to market.

As a full-service CRO, our offering is tailored to meet your specific clinical research needs:
• Clinical Trial Services
• Medical Monitoring
• Medical Imaging Solutions
• Medical Research & Development
• Medical Writing
• Precision Medicine/Biomarkers
• Clinical Pharmacology
• Histopathology via Specialty Lab, AcelaBio
• Spatial Biology
• Statistics
• Real-World Evidence

Headquartered in London, Ontario, Alimentiv operates with globally across Canada, the US, Europe, Asia-Pacific, and Latin America.